Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/29/2007US20070275096 Composition and methodology for the treatment of hearing impairment symptoms
11/29/2007US20070275095 Treatment of inflammatory, autoimmune, or other disorders, using agents that reduce the sequestering of zinc by calprotectin
11/29/2007US20070275094 Isothiazolinone biocides enhanced by zinc ions
11/29/2007US20070275093 Methods for Treating Non-Microbial Inflammatory Skin Conditioners
11/29/2007US20070275092 Therapeutic composition supporting the immune system
11/29/2007US20070275091 Compositions And Methods For Improved Mucus Function
11/29/2007US20070275083 ameliorating chronic renal insufficiency, hypertension, atherosclerosis, and chronic congestive heart failure
11/29/2007US20070275078 Microcapsules for the Administration of Active Ingredients
11/29/2007US20070275075 Ezetimibe compositions
11/29/2007US20070275071 Use of Microparticles for Antigen Delivery
11/29/2007US20070275069 Hydrophobic biomolecular structure
11/29/2007US20070275067 Compression Coated Tablet Comprising Sumatriptan
11/29/2007US20070275066 Sustained release drug delivery system composed of water insoluble polymer
11/29/2007US20070275065 Controlled release oxycodone compositions
11/29/2007US20070275064 Solid Tablets Composition Rapidly Dissolvable in Water or Watery Liquids and Used for Body, Skin, Hair and Oral Hygiene and Desinfection
11/29/2007US20070275063 Sustained release pharmaceutical compositions and methods of treatment using the same
11/29/2007US20070275062 Use of oral dosage form prepared by forming granules comprising oxycodone hydrochloride, spray-dried lactose, Eudragit (reg), talc and magnesium stearate and drying said granules; improving efficiency and quality of pain management
11/29/2007US20070275061 Pharmaceutical compositions and formulations of metformin extended release tablets
11/29/2007US20070275060 Extended release solid pharmaceutical composition containing carbidopa and levodopa
11/29/2007US20070275059 Flashmelt oral dosage formulation
11/29/2007US20070275057 Formulation and Process for the Preparation of Modafinil
11/29/2007US20070275056 Method for treating minor aphthous ulcers
11/29/2007US20070275055 Compositions capable of facilitating penetration across a biological barrier
11/29/2007US20070275054 Novel composition and use
11/29/2007US20070275052 Pharmaceutical compositions containing sterol inhibitors
11/29/2007US20070275051 Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
11/29/2007US20070275048 Liposome composition for delivery of a therapeutic agent to eyes
11/29/2007US20070275046 Noval Surfactants and Applications Thereof
11/29/2007US20070275033 Biodegradable polyurethane and polyurethane ureas
11/29/2007US20070275032 Use Of A Mixture For The Production Of An Agent For Treating Defective Or Degenerated Cartilage In The Production Of Natural Cartilage Replacement In Vitro
11/29/2007US20070275031 Implantable polymeric device for sustained release of buprenorphine with minimal initial burst
11/29/2007US20070275026 Therapeutic Use of a Growth Factor, NsG33
11/29/2007US20070275024 Starch Films and Uses Thereof
11/29/2007US20070275019 Vaccines directed to cancer-associated carbohydrate antigens
11/29/2007US20070275018 Relates to gene NcSAG4, the RNA messenger of said gene, the oligonucleotides designed based on the nucleotide sequence thereof, and to protein NcSAG4 encoded thereby, and expression vectors, for the purpose of diagnosis and vaccination for the prevention of neosporosis
11/29/2007US20070275007 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof as Antimetastatic Agents in Treating Cancer
11/29/2007US20070275003 polynucleotides that code for HPV E6/E7 fusion proteins, having mutagenesis points, used to generate immune responses against HPV and prevent or treat cervical cancer
11/29/2007US20070275002 Use Of Proteins And Peptides Encoded By The Genome Of A Novel Sars-Associated Coronavirus Strain
11/29/2007US20070274990 Novel Therapeutic Targets in Cancer
11/29/2007US20070274988 Kiaa0779, Splice Variants Thereof, and Methods of Their Use
11/29/2007US20070274983 Nutritional Composition Comprising Immunoglobulins and Oligosaccharides
11/29/2007US20070274973 Method of controlling fungal pathogens, and agents useful for same
11/29/2007US20070274955 Novel Galactooligosaccharide Composition and the Preparation Thereof
11/29/2007US20070274953 Photochemical internalization for delivery of molecules into the cytosol
11/29/2007US20070274952 Compositions and Methods for Modifying the Content of Polyunsaturated Fatty Acids in Biological Cells
11/29/2007US20070274951 Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related thereto
11/29/2007US20070274947 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1 and Uses Thereof in the Treatment of Cancer
11/29/2007US20070274945 High molecular weight chelation structure
11/29/2007US20070274944 Antimicrobial composition of 3-iodo-2-propynylbutyl carbamate and 1,3-butylene glycol as solvent
11/29/2007US20070274940 Method of enhancing the control of viruses on skin
11/29/2007US20070274936 Oligonucleotide and the Use Thereof for Modulating an Isoform C Beta-1 Protein-Kinase in the Form of a Skin Depigmentation Agent
11/29/2007US20070274935 Method for treatment of onychomycosis
11/29/2007US20070274933 Amino- and hydroxysubstituted triphenyl-S-triazines as stabilizers
11/29/2007US20070274928 Novel Cyclic Oxygenated Compounds Having Cooling, Fragrance, and Flavor Properties, and Uses Thereof
11/29/2007US20070274926 Method of inhibiting the transmission of viruses
11/29/2007US20070274925 Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
11/29/2007US20070274922 such as 2-((methylamino)methyl)quinoline-8-yl-boronic acid
11/29/2007US20070274920 neurophysiological assay using information obtained from injecting a neural activity blocker, such as tetrodotoxin, into one hippocampus persistently coactivated pyramidal cell in the uninjected hippocampus that initially discharged independently
11/29/2007US20070274918 Software system using a three-dimensional model of a crystal LINGO-1 polypeptide to design an agent that binds LINGO-1 and disables the Nogo; receptor complex; LINGO-1 signaling a negative regulator of myelin production; Lingo-1 antagonists; drug design; multiple sclerosis
11/29/2007US20070274917 Pharmacologic Method Of Lowering Cholesterol Production
11/29/2007US20070274916 Method for Identifying Compounds that Affect Expression of Tryptophan Hydroxylase Isoform 2
11/29/2007US20070274913 Preventives/Remedies for Stress Urinary Incontinence and Method of Screening the Same
11/29/2007US20070274910 e.g. 3-[2-(2-Aminophenyl)ethyl]-8-benzyl-7-(2-methylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility
11/29/2007US20070274908 Methods and compositions related to adenoassociated virus-phage particles
11/29/2007US20070274907 Magnetically Targetable Mitomycin C Compositions and Methods of Their Use
11/29/2007DE202007011042U1 Polymorphe Formen von Flupirtinmaleat Polymorphic forms of flupirtine maleate
11/29/2007DE20023915U1 Oxidativ stabile langkettige Ethylester-Weichmacher Oxidatively stable long-chain ethyl ester plasticizer
11/29/2007DE19531342B4 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators
11/29/2007DE102006024911A1 Solubilizate of plant extract that contains active agent, useful as additive for e.g. cosmetics, pharmaceuticals and foods, includes water and emulsifier
11/29/2007DE102006024834A1 Neue Indol-Pyrrol-Derivate und deren Verwendung New indole-pyrrole derivatives and their use
11/29/2007DE102006024748A1 Proteasen-Inhibitor zur Wundbehandlung Protease inhibitor for the treatment of wounds
11/29/2007DE102006024528A1 Neue, an der Tumorphysiologie orientierte Formulierung eines Zytostatikums, insbesondere von cis-Platin Last, based on the formulation of a cytostatic tumor physiology, in particular cis-platinum
11/29/2007DE102006024024A1 Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung Substituted Arylimidazolone and -triazolone and their use
11/29/2007DE102006023756A1 Ethanolhaltige Aerosolformulierung für die Inhalation Ethanol-containing aerosol formulation for inhalation
11/29/2007CA2688206A1 Novel indol-pyrrol derivatives for the treatment of proliferative and inflammatory diseases
11/29/2007CA2687451A1 Bacterial thioredoxin reductase inhibitors and methods for use thereof
11/29/2007CA2669813A1 Substituted aryl piperidinylalkynyladenosines as a2ar agonists
11/29/2007CA2666293A1 Melatonin agonist treatment
11/29/2007CA2653647A1 C-glycolipids with enhanced th-1 profile
11/29/2007CA2653538A1 Impurities of donepezil
11/29/2007CA2653117A1 Substituted pteridines substituted with a four-membered heterocycle
11/29/2007CA2653111A1 Inhalant aerosol formulations containing ethanol
11/29/2007CA2653105A1 Novel medicament combinations for the treatment of respiratory diseases
11/29/2007CA2653091A1 Maternal supplement comprising docosahexaenoic acid to prevent obesity in infants and children
11/29/2007CA2653085A1 Aqueous solution of 20(r)-ginsenoside rg3 pharmaceutical composition and process thereof
11/29/2007CA2653062A1 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
11/29/2007CA2653042A1 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
11/29/2007CA2652903A1 Process for producing nanoparticles by spray drying
11/29/2007CA2652857A1 Crystalline a and b forms of a maleate salt of 5-amino-3- (2 ', 3 '-di-o-acetyl-beta-d-ribofuranosyl) -3h-thiazolo [4, 5-d] pyrimidin-2-one
11/29/2007CA2652841A1 New benzothiazinone derivatives and their use as antibacterial agents
11/29/2007CA2652840A1 2-piperazino-6-chloro-pteridines as pde4-inhibitors for the treatment of inflammatory diseases
11/29/2007CA2652838A1 Bilayer tablet for preventing cardiovascular events
11/29/2007CA2652797A1 Methods for the delivery of a .beta.2 agonist to induce bronchodilation and formulations for use in the same
11/29/2007CA2652783A1 Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis
11/29/2007CA2652770A1 Rnai modulation of aha and therapeutic uses thereof
11/29/2007CA2652758A1 Reversion of malignant phenotype with 9-hydroxy ellipticine derivatives
11/29/2007CA2652751A1 Pharmaceutical compositions and methods of using same
11/29/2007CA2652707A1 C-phenyl glycitol compound
11/29/2007CA2652699A1 Propellant-free inhalation aerosol formulation containing ipratropium bromide and salbutamol sulfate
11/29/2007CA2652697A1 Inhalant propellant-free aerosol formulation
1 ... 3482 3483 3484 3485 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 ... 7860